메뉴 건너뛰기




Volumn 17, Issue 1, 2015, Pages

Circulating DNA as biomarker in breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MASPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG; TUMOR MARKER;

EID: 84943643372     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-015-0645-5     Document Type: Review
Times cited : (91)

References (52)
  • 1
    • 84957852098 scopus 로고
    • Les acides nucléiques du plasma sanguin chez l'homme (Nucleic acids in human blood plasma)
    • Mandel P, Métais P. Les acides nucléiques du plasma sanguin chez l'homme (Nucleic acids in human blood plasma). C R Acad Sci Paris. 1948;142:241-3.
    • (1948) C R Acad Sci Paris , vol.142 , pp. 241-243
    • Mandel, P.1    Métais, P.2
  • 2
    • 0017360626 scopus 로고
    • Free DNA in the serum of cancer patients and the effect of therapy
    • Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646-50.
    • (1977) Cancer Res , vol.37 , pp. 646-650
    • Leon, S.A.1    Shapiro, B.2    Sklaroff, D.M.3    Yaros, M.J.4
  • 3
    • 0033168068 scopus 로고    scopus 로고
    • Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations
    • Silva JM, Dominguez G, Garcia JM, Gonzalez R, Villanueva MJ, Navarro F, et al. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res. 1999;59:3251-6.
    • (1999) Cancer Res , vol.59 , pp. 3251-3256
    • Silva, J.M.1    Dominguez, G.2    Garcia, J.M.3    Gonzalez, R.4    Villanueva, M.J.5    Navarro, F.6
  • 7
    • 0034750559 scopus 로고    scopus 로고
    • About the possible origin and mechanism of circulating DNA apoptosis and active DNA release
    • Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta. 2001;313:139-42.
    • (2001) Clin Chim Acta , vol.313 , pp. 139-142
    • Stroun, M.1    Lyautey, J.2    Lederrey, C.3    Olson-Sand, A.4    Anker, P.5
  • 8
    • 0026674790 scopus 로고
    • Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance
    • Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR. Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol. 1992;90:56-62.
    • (1992) Clin Exp Immunol , vol.90 , pp. 56-62
    • Rumore, P.1    Muralidhar, B.2    Lin, M.3    Lai, C.4    Steinman, C.R.5
  • 9
    • 79957458567 scopus 로고    scopus 로고
    • Cell-free nucleic acids as biomarkers in cancer patients
    • Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426-37.
    • (2011) Nat Rev Cancer , vol.11 , pp. 426-437
    • Schwarzenbach, H.1    Hoon, D.S.2    Pantel, K.3
  • 10
    • 0035866393 scopus 로고    scopus 로고
    • DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells
    • Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659-65.
    • (2001) Cancer Res , vol.61 , pp. 1659-1665
    • Jahr, S.1    Hentze, H.2    Englisch, S.3    Hardt, D.4    Fackelmayer, F.O.5    Hesch, R.D.6
  • 12
    • 71049146803 scopus 로고    scopus 로고
    • Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
    • Kohler C, Radpour R, Barekati Z, Asadollahi R, Bitzer J, Wight E, et al. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer. 2009;8:105.
    • (2009) Mol Cancer , vol.8 , pp. 105
    • Kohler, C.1    Radpour, R.2    Barekati, Z.3    Asadollahi, R.4    Bitzer, J.5    Wight, E.6
  • 13
    • 78650878367 scopus 로고    scopus 로고
    • Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
    • Roth C, Pantel K, Muller V, Rack B, Kasimir-Bauer S, Janni W, et al. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression. BMC Cancer. 2011;11:4.
    • (2011) BMC Cancer , vol.11 , pp. 4
    • Roth, C.1    Pantel, K.2    Muller, V.3    Rack, B.4    Kasimir-Bauer, S.5    Janni, W.6
  • 14
    • 84878965534 scopus 로고    scopus 로고
    • Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin
    • Stoetzer OJ, Fersching DM, Salat C, Steinkohl O, Gabka CJ, Hamann U, et al. Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin. Cancer Lett. 2013;336:140-8.
    • (2013) Cancer Lett , vol.336 , pp. 140-148
    • Stoetzer, O.J.1    Fersching, D.M.2    Salat, C.3    Steinkohl, O.4    Gabka, C.J.5    Hamann, U.6
  • 15
  • 16
    • 84871630944 scopus 로고    scopus 로고
    • Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
    • Benesova L, Belsanova B, Suchanek S, Kopeckova M, Minarikova P, Lipska L, et al. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Anal Biochem. 2013;433:227-34.
    • (2013) Anal Biochem , vol.433 , pp. 227-234
    • Benesova, L.1    Belsanova, B.2    Suchanek, S.3    Kopeckova, M.4    Minarikova, P.5    Lipska, L.6
  • 18
    • 84887612347 scopus 로고    scopus 로고
    • Circulating nucleic acids as biomarkers in breast cancer
    • Schwarzenbach H. Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Res. 2013;15:211.
    • (2013) Breast Cancer Res , vol.15 , pp. 211
    • Schwarzenbach, H.1
  • 20
    • 33749260689 scopus 로고    scopus 로고
    • Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients
    • Huang ZH, Li LH, Hua D. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett. 2006;243:64-70.
    • (2006) Cancer Lett , vol.243 , pp. 64-70
    • Huang, Z.H.1    Li, L.H.2    Hua, D.3
  • 21
    • 80052736273 scopus 로고    scopus 로고
    • Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease
    • Schwarzenbach H, Muller V, Milde-Langosch K, Steinbach B, Pantel K. Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease. Mol Biosyst. 2011;7:2848-54.
    • (2011) Mol Biosyst , vol.7 , pp. 2848-2854
    • Schwarzenbach, H.1    Muller, V.2    Milde-Langosch, K.3    Steinbach, B.4    Pantel, K.5
  • 22
    • 84856435964 scopus 로고    scopus 로고
    • The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
    • Payne RE, Hava NL, Page K, Blighe K, Ward B, Slade M, et al. The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy. Br J Cancer. 2012;106:375-82.
    • (2012) Br J Cancer , vol.106 , pp. 375-382
    • Payne, R.E.1    Hava, N.L.2    Page, K.3    Blighe, K.4    Ward, B.5    Slade, M.6
  • 23
    • 33748924308 scopus 로고    scopus 로고
    • Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics
    • Klein CA, Holzel D. Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics. Cell Cycle. 2006;5:1788-98.
    • (2006) Cell Cycle , vol.5 , pp. 1788-1798
    • Klein, C.A.1    Holzel, D.2
  • 26
    • 84903692972 scopus 로고    scopus 로고
    • Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
    • Madhavan D, Wallwiener M, Bents K, Zucknick M, Nees J, Schott S, et al. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat. 2014;146:163-74.
    • (2014) Breast Cancer Res Treat , vol.146 , pp. 163-174
    • Madhavan, D.1    Wallwiener, M.2    Bents, K.3    Zucknick, M.4    Nees, J.5    Schott, S.6
  • 27
    • 84883590118 scopus 로고    scopus 로고
    • Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy
    • Lehner J, Stotzer OJ, Fersching D, Nagel D, Holdenrieder S. Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy. Clin Chim Acta. 2013;425:206-11.
    • (2013) Clin Chim Acta , vol.425 , pp. 206-211
    • Lehner, J.1    Stotzer, O.J.2    Fersching, D.3    Nagel, D.4    Holdenrieder, S.5
  • 28
    • 84898542288 scopus 로고    scopus 로고
    • Liquid biopsies: genotyping circulating tumor DNA
    • Diaz Jr LA, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32:579-86.
    • (2014) J Clin Oncol , vol.32 , pp. 579-586
    • Diaz, L.A.1    Bardelli, A.2
  • 31
    • 84863011201 scopus 로고    scopus 로고
    • Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
    • Shaw JA, Page K, Blighe K, Hava N, Guttery D, Ward B, et al. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res. 2012;22:220-31.
    • (2012) Genome Res , vol.22 , pp. 220-231
    • Shaw, J.A.1    Page, K.2    Blighe, K.3    Hava, N.4    Guttery, D.5    Ward, B.6
  • 32
    • 84928186818 scopus 로고    scopus 로고
    • PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer
    • 283ra251
    • Bosch A, Li Z, Bergamaschi A, Ellis H, Toska E, Prat A, et al. PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer. Sci Transl Med. 2015;7:283ra251.
    • (2015) Sci Transl Med , vol.7
    • Bosch, A.1    Li, Z.2    Bergamaschi, A.3    Ellis, H.4    Toska, E.5    Prat, A.6
  • 33
    • 84925460062 scopus 로고    scopus 로고
    • PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
    • Oshiro C, Kagara N, Naoi Y, Shimoda M, Shimomura A, Maruyama N, et al. PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients. Breast Cancer Res Treat. 2015;150:299-307.
    • (2015) Breast Cancer Res Treat , vol.150 , pp. 299-307
    • Oshiro, C.1    Kagara, N.2    Naoi, Y.3    Shimoda, M.4    Shimomura, A.5    Maruyama, N.6
  • 34
    • 84921758615 scopus 로고    scopus 로고
    • Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
    • Rothe F, Laes JF, Lambrechts D, Smeets D, Vincent D, Maetens M, et al. Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer. Ann Oncol. 2014;25:1959-65.
    • (2014) Ann Oncol , vol.25 , pp. 1959-1965
    • Rothe, F.1    Laes, J.F.2    Lambrechts, D.3    Smeets, D.4    Vincent, D.5    Maetens, M.6
  • 35
    • 84896371874 scopus 로고    scopus 로고
    • Detection of circulating tumor DNA in early- and late-stage human malignancies
    • Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224ra224.
    • (2014) Sci Transl Med , vol.6 , pp. 224ra224
    • Bettegowda, C.1    Sausen, M.2    Leary, R.J.3    Kinde, I.4    Wang, Y.5    Agrawal, N.6
  • 37
    • 84877579861 scopus 로고    scopus 로고
    • Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
    • Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013;497:108-12.
    • (2013) Nature , vol.497 , pp. 108-112
    • Murtaza, M.1    Dawson, S.J.2    Tsui, D.W.3    Gale, D.4    Forshew, T.5    Piskorz, A.M.6
  • 39
    • 82455218972 scopus 로고    scopus 로고
    • Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
    • Gobel G, Auer D, Gaugg I, Schneitter A, Lesche R, Muller-Holzner E, et al. Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. Breast Cancer Res Treat. 2011;130:109-17.
    • (2011) Breast Cancer Res Treat , vol.130 , pp. 109-117
    • Gobel, G.1    Auer, D.2    Gaugg, I.3    Schneitter, A.4    Lesche, R.5    Muller-Holzner, E.6
  • 40
    • 84857911910 scopus 로고    scopus 로고
    • Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARbeta2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay
    • Yamamoto N, Nakayama T, Kajita M, Miyake T, Iwamoto T, Kim SJ, et al. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARbeta2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay. Breast Cancer Res Treat. 2012;132:165-73.
    • (2012) Breast Cancer Res Treat , vol.132 , pp. 165-173
    • Yamamoto, N.1    Nakayama, T.2    Kajita, M.3    Miyake, T.4    Iwamoto, T.5    Kim, S.J.6
  • 41
    • 84865853256 scopus 로고    scopus 로고
    • Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR Is predictive of poor prognosis for breast cancer patients
    • Fujita N, Nakayama T, Yamamoto N, Kim SJ, Shimazu K, Shimomura A, et al. Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR Is predictive of poor prognosis for breast cancer patients. Oncology. 2012;83:273-82.
    • (2012) Oncology , vol.83 , pp. 273-282
    • Fujita, N.1    Nakayama, T.2    Yamamoto, N.3    Kim, S.J.4    Shimazu, K.5    Shimomura, A.6
  • 42
    • 64949112189 scopus 로고    scopus 로고
    • The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
    • Van der Auwera I, Elst HJ, Van Laere SJ, Maes H, Huget P, van Dam P, et al. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer. 2009;100:1277-86.
    • (2009) Br J Cancer , vol.100 , pp. 1277-1286
    • Auwera, I.1    Elst, H.J.2    Laere, S.J.3    Maes, H.4    Huget, P.5    Dam, P.6
  • 43
    • 13944250245 scopus 로고    scopus 로고
    • Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients
    • Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 2005;65:1141-5.
    • (2005) Cancer Res , vol.65 , pp. 1141-1145
    • Fiegl, H.1    Millinger, S.2    Mueller-Holzner, E.3    Marth, C.4    Ensinger, C.5    Berger, A.6
  • 44
    • 84864423461 scopus 로고    scopus 로고
    • Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    • Avraham A, Uhlmann R, Shperber A, Birnbaum M, Sandbank J, Sella A, et al. Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. Int J Cancer. 2012;131:E1166-72.
    • (2012) Int J Cancer , vol.131 , pp. E1166-E1172
    • Avraham, A.1    Uhlmann, R.2    Shperber, A.3    Birnbaum, M.4    Sandbank, J.5    Sella, A.6
  • 45
    • 84893186983 scopus 로고    scopus 로고
    • ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
    • Martinez-Galan J, Torres-Torres B, Nunez MI, Lopez-Penalver J, Del Moral R, Ruiz De Almodovar JM, et al. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients. BMC Cancer. 2014;14:59.
    • (2014) BMC Cancer , vol.14 , pp. 59
    • Martinez-Galan, J.1    Torres-Torres, B.2    Nunez, M.I.3    Lopez-Penalver, J.4    Moral, R.5    Ruiz De Almodovar, J.M.6
  • 46
    • 84907985819 scopus 로고    scopus 로고
    • Estrogen receptor alpha (ERalpha) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients
    • Hagrass HA, Pasha HF, Ali AM. Estrogen receptor alpha (ERalpha) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients. Gene. 2014;552:81-6.
    • (2014) Gene , vol.552 , pp. 81-86
    • Hagrass, H.A.1    Pasha, H.F.2    Ali, A.M.3
  • 47
    • 84929674483 scopus 로고    scopus 로고
    • Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer
    • Fu D, Ren C, Tan H, Wei J, Zhu Y, He C, et al. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer. Medicine (Baltimore). 2015;94:e637.
    • (2015) Medicine (Baltimore) , vol.94 , pp. e637
    • Fu, D.1    Ren, C.2    Tan, H.3    Wei, J.4    Zhu, Y.5    He, C.6
  • 48
    • 84872031717 scopus 로고    scopus 로고
    • SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer
    • Chimonidou M, Strati A, Malamos N, Georgoulias V, Lianidou ES. SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer. Clin Chem. 2012;59:270-9.
    • (2012) Clin Chem , vol.59 , pp. 270-279
    • Chimonidou, M.1    Strati, A.2    Malamos, N.3    Georgoulias, V.4    Lianidou, E.S.5
  • 50
    • 78751569876 scopus 로고    scopus 로고
    • Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression
    • Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, et al. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol. 2011;32:23-32.
    • (2011) Tumour Biol , vol.32 , pp. 23-32
    • Sharma, G.1    Mirza, S.2    Parshad, R.3    Srivastava, A.4    Gupta, S.D.5    Pandya, P.6
  • 51
    • 84903196176 scopus 로고    scopus 로고
    • Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity
    • Guerrero-Preston R, Hadar T, Ostrow KL, Soudry E, Echenique M, Ili-Gangas C, et al. Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity. Oncol Rep. 2014;32:505-12.
    • (2014) Oncol Rep , vol.32 , pp. 505-512
    • Guerrero-Preston, R.1    Hadar, T.2    Ostrow, K.L.3    Soudry, E.4    Echenique, M.5    Ili-Gangas, C.6
  • 52
    • 84868368069 scopus 로고    scopus 로고
    • Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls
    • Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF. Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics. 2012;7:1258-67.
    • (2012) Epigenetics , vol.7 , pp. 1258-1267
    • Sturgeon, S.R.1    Balasubramanian, R.2    Schairer, C.3    Muss, H.B.4    Ziegler, R.G.5    Arcaro, K.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.